Company · CIK 0001459450
Myrexis, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Jun 30
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 4Insider trades0000921895-21-002138 · 16.5 KBSEC(opens sec.gov)
- 3Myrexis, Inc.0000921895-20-000957 · 4.9 KBSEC(opens sec.gov)
- 10-K/AMyrexis, Inc.0000921895-13-001482 · 567.1 KBSEC(opens sec.gov)
- 10-KAnnual report0001144204-13-039919 · 8.0 MBSEC(opens sec.gov)
- 10-QQuarterly update0001144204-13-027684 · 2.5 MBSEC(opens sec.gov)
- 8-KCurrent report0000921895-13-000885 · 122.9 KBSEC(opens sec.gov)
- 8-KCurrent report0000921895-13-000823 · 40.7 KBSEC(opens sec.gov)
- 3Myrexis, Inc.0000921895-13-000546 · 6.3 KBSEC(opens sec.gov)
- SC 13DMyrexis, Inc.0000921895-13-000543 · 228.5 KBSEC(opens sec.gov)
- 8-KCurrent report0000921895-13-000503 · 40.9 KBSEC(opens sec.gov)
Insiders
- Aryeh JasonDirector
- Belle Gerald P.Director
- Berry BarbaraSVP, Human Resources
- BREWER RICHARD BDirector, President and CEO
- COUCHMAN JONATHANDirector, Chairman, President and CEO
- First Eagle Investment Management, LLC10% Owner
- Forrester RobertDirector
- Franson Timothy RDirector
- Gibbs AndrewVP, General Counsel
- GRYSKA DAVID WDirector, Chief Operating Officer
Tickers
No tickers on record.
Addresses
business
600 FIFTH AVENUE, 2ND FLOOR
NEW YORK, NY, 10020
mailing
600 FIFTH AVENUE, 2ND FLOOR
NEW YORK, NY, 10020
Former names
- Myriad Pharmaceuticals, Inc.2010-06-18
Same industry